4.5 Review

Cancer cell metabolism as new targets for novel designed therapies

期刊

FUTURE MEDICINAL CHEMISTRY
卷 6, 期 16, 页码 1791-1810

出版社

FUTURE SCI LTD
DOI: 10.4155/FMC.14.119

关键词

-

资金

  1. European Commission METAFLUX [Marie Curie FP7-PEOPLE-2010 ITN-264780]
  2. Spanish Government [SAF2011-25726]
  3. European Union FEDER [SAF2011-25726]
  4. Generalitat de Catalunya [2014SGR-1017]
  5. Generalitat de Catalunya (Icrea Academia award)

向作者/读者索取更多资源

Metabolic processes are altered in cancer cells, which obtain advantages from this metabolic reprogramming in terms of energy production and synthesis of biomolecules that sustain their uncontrolled proliferation. Due to the conceptual progresses in the last decade, metabolic reprogramming was recently included as one of the new hallmarks of cancer. The advent of high-throughput technologies to amass an abundance of omic data, together with the development of new computational methods that allow the integration and analysis of omic data by using genome-scale reconstructions of human metabolism, have increased and accelerated the discovery and development of anticancer drugs and tumor-specific metabolic biomarkers. Here we review and discuss the latest advances in the context of metabolic reprogramming and the future in cancer research.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biotechnology & Applied Microbiology

Soft-sensors application for automated feeding control in high-throughput mammalian cell cultures

Ivan Martinez-Monge, Carlos Martinez, Marianne Decker, Isuru A. Udugama, Igor Marin de Mas, Krist Gernaey, Lars K. Nielsen

Summary: A new soft-sensor-based fed-batch strategy has been developed to maintain substrate concentration at optimal levels in cell cultures.

BIOTECHNOLOGY AND BIOENGINEERING (2022)

Article Biochemistry & Molecular Biology

TKTL1 Knockdown Impairs Hypoxia-Induced Glucose-6-phosphate Dehydrogenase and Glyceraldehyde-3-phosphate Dehydrogenase Overexpression

Ines Baptista, Effrosyni Karakitsou, Jean-Baptiste Cazier, Ulrich L. Guenther, Silvia Marin, Marta Cascante

Summary: Through TKTL1 knockdown experiments, it was found that TKTL1 plays a key role in the metabolic adaptation to hypoxia in THP-1 AML cells by modulating the activities of G6PD and GAPDH, which involve changes in redox capacity and transcriptional regulation of key enzymes and transporters related to glucose, PPP, and amino acid metabolism.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Multidisciplinary Sciences

The Glycolytic Gatekeeper PDK1 defines different metabolic states between genetically distinct subtypes of human acute myeloid leukemia

Aysegul Erdem, Silvia Marin, Diego A. Pereira-Martins, Roldan Cortes, Alan Cunningham, Maurien G. Pruis, Bauke de Boer, Fiona A. J. van den Heuvel, Marjan Geugien, Albertus T. J. Wierenga, Annet Z. Brouwers-Vos, Eduardo M. Rego, Gerwin Huls, Marta Cascante, Jan Jacob Schuringa

Summary: This study uncovers the metabolic heterogeneity of acute myeloid leukemia (AML) and identifies Pyruvate dehydrogenase kinase 1 (PDK1) as a targetable determinant of different metabolic states in distinct subtypes of AML. This finding provides potential targets for the treatment of AML, a genetically heterogeneous disease.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

Inhibition of the succinyl dehydrogenase complex in acute myeloid leukemia leads to a lactate-fuelled respiratory metabolic vulnerability

Aysegul Erdem, Silvia Marin, Diego A. Pereira-Martins, Marjan Geugien, Alan Cunningham, Maurien G. Pruis, Isabel Weinhauser, Albert Gerding, Barbara M. Bakker, Albertus T. J. Wierenga, Eduardo M. Rego, Gerwin Huls, Marta Cascante, Jan Jacob Schuringa

Summary: This study reveals that FLT3-ITD + acute myeloid leukemia cells rely on oxidative phosphorylation and inhibition of complex II activity leads to increased lactate influx, driving respiration and providing a targetable vulnerability.

NATURE COMMUNICATIONS (2022)

Article Medicine, General & Internal

Targeted Metabolomics Shows That the Level of Glutamine, Kynurenine, Acyl-Carnitines and Lysophosphatidylcholines Is Significantly Increased in the Aqueous Humor of Glaucoma Patients

Alejandro Lillo, Silvia Marin, Joan Serrano-Marin, Nicolas Binetti, Gemma Navarro, Marta Cascante, Juan Sanchez-Naves, Rafael Franco

Summary: This study aimed to explore the differences in small metabolite concentrations in the aqueous humor of glaucoma patients and healthy subjects, finding that 57 compounds were significantly increased in glaucoma patients. Glaucoma may lead to mitochondrial abnormalities, so the increased glutamine can control the concentration of glutamate, avoiding the risk of neuronal and retinal cell death.

FRONTIERS IN MEDICINE (2022)

Article Oncology

A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study

Marta Espanol-Rego, Carlos Fernandez-Martos, Elena Elez, Carles Foguet, Leire Pedrosa, Nuria Rodriguez, Ana Ruiz-Casado, Estela Pineda, Joan Cid, Raquel Cabezon, Helena Oliveres, Miquel Lozano, Angels Gines, Angeles Garcia-Criado, Juan Ramon Ayuso, Mario Pages, Miriam Cuatrecasas, Ferran Torres, Timothy Thomson, Marta Cascante, Daniel Benitez-Ribas, Joan Maurel

Summary: This study investigated the potential of Avelumab combined with ADC vaccine as a treatment for MSS mCRC patients. The results showed that the combination therapy was safe and well tolerated, but had limited clinical activity. Additionally, the study found a post-therapy metabolic rewiring, which could represent novel immunotherapy-induced tumor vulnerabilities.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)

Article Biochemistry & Molecular Biology

Biogenic Amine Levels Markedly Increase in the Aqueous Humor of Individuals with Controlled Type 2 Diabetes

Alejandro Lillo, Silvia Marin, Joan Serrano-Marin, David Bernal-Casas, Nicolas Binetti, Gemma Navarro, Marta Cascante, Juan Sanchez-Naves, Rafael Franco

Summary: The composition of aqueous humor in patients with type 2 diabetes is different from that in healthy subjects, and certain molecules can serve as potential markers for discriminating between control and diabetes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Immunology

A novel gene signature unveils three distinct immune-metabolic rewiring patterns conserved across diverse tumor types and associated with outcomes

Leire Pedrosa, Carles Foguet, Helena Oliveres, Ivan Archilla, Marta Garcia de Herreros, Adela Rodriguez, Antonio Postigo, Daniel Benitez-Ribas, Jordi Camps, Miriam Cuatrecasas, Antoni Castells, Aleix Prat, Timothy M. Thomson, Joan Maurel, Marta Cascante

Summary: In this study, researchers developed an immune-metabolic signature suitable for personalized immune checkpoint inhibitor therapies. The signature classified tumors into three distinct immune-metabolic clusters, providing a new predictive tool for patient selection for specific immune-metabolic therapeutic approaches.

FRONTIERS IN IMMUNOLOGY (2022)

Article Medicine, General & Internal

An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers

Artur Mezheyeuski, Max Backman, Johanna Mattsson, Alfonso Martin-Bernabe, Chatarina Larsson, Ina Hrynchyk, Klara Hammarstrom, Simon Strom, Joakim Ekstrom, Siarhei Mauchanski, Salome Khelashvili, Amanda Lindberg, Margret Agnarsdottir, Per-Henrik Edqvist, Jutta Huvila, Ulrika Segersten, Per-Uno Malmstrom, Johan Botling, Bjoern Nodin, Charlotta Hedner, David Borg, Jenny Brandstedt, Hanna Sartor, Karin Leandersson, Bengt Glimelius, Anna Portyanko, Fredrik Ponten, Karin Jirstrom, Patrick Micke, Tobias Sjoblom

Summary: We evaluated 15 immune cell classes in 1481 tumor samples and generated an immune activation signature (SIA) based on the prognostic information of CD8+ lymphocytes and CD68+CD163+ macrophages in various cancer types. The SIA was associated with patient survival and had predictive value for response to checkpoint inhibitor therapy.

EBIOMEDICINE (2023)

Article Biochemistry & Molecular Biology

An Assessment of Quaternary Structure Functionality in Homomer Protein Complexes

Gyorgy Abrusan, Carles Foguet

Summary: It has been suggested that a significant fraction of homomer protein-protein interfaces evolve neutrally, without contributing to function, due to a hydrophobic bias in missense mutations. However, the fraction of such gratuitous complexes is currently unknown. In this study, the researchers quantified the fraction of homodimers where multimerization is unlikely to contribute to their biochemical function. They found that ligand binding-site structure predicts whether a homomer is functional or not, and that the hydrophobicity of interfaces changes little with the strength of selection. Additionally, they observed that MBS homomer interfaces coevolve more strongly with ligand binding sites than the interfaces of SBS homomers.

MOLECULAR BIOLOGY AND EVOLUTION (2023)

Article Multidisciplinary Sciences

An atlas of genetic scores to predict multi-omic traits

Yu Xu, Scott C. Ritchie, Yujian Liang, Paul R. H. J. Timmers, Maik Pietzner, Loïc Lannelongue, Samuel A. Lambert, Usman A. Tahir, Sebastian May-Wilson, Carles Foguet, Asa Johansson, Praveen Surendran, Artika P. Nath, Elodie Persyn, James E. Peters, Clare Oliver-Williams, Shuliang Deng, Bram Prins, Jian'an Luan, Lorenzo Bomba, Nicole Soranzo, Emanuele Di Angelantonio, Nicola Pirastu, E. Shyong Tai, Rob M. van Dam, Helen Parkinson, Emma E. Davenport, Dirk S. Paul, Christopher Yau, Robert E. Gerszten, Anders Maelarstig, John Danesh, Xueling Sim, Claudia Langenberg, James F. Wilson, Adam S. Butterworth, Michael Inouye

Summary: This study investigates the use of omic modalities in dissecting the molecular underpinnings of common diseases and traits. It examines a large cohort with extensive multi-omic data and uses machine learning to train genetic scores for various molecular traits. The study evaluates the performance of these genetic scores through external validation across different ancestral cohorts and highlights key biological insights related to metabolism and disease pathways. A web portal is also developed to provide public access to the genetic scores and validation results.

NATURE (2023)

Article Biology

Control analysis in the identification of key enzymes driving metabolic adaptations: Towards drug target discovery

Pedro de Atauri, Carles Foguet, Marta Cascante

Summary: Metabolic Control Analysis (MCA) has revealed that control of metabolic pathways is distributed among many enzymes and depends on kinetic determinants in addition to stoichiometric structure. By incorporating kinetic determinants and ruling out enzymes with low control coefficients, MCA can improve the prediction and identification of therapeutic targets in drug discovery.

BIOSYSTEMS (2023)

Article Biochemistry & Molecular Biology

Circulating Neurofilament Light Chain Levels Increase with Age and Are Associated with Worse Physical Function and Body Composition in Men but Not in Women

Xavier Capo, Aina Maria Galmes-Panades, Cayetano Navas-Enamorado, Ana Ortega-Moral, Silvia Marin, Marta Cascante, Andres Sanchez-Polo, Luis Masmiquel, Margalida Torrens-Mas, Marta Gonzalez-Freire

Summary: This study investigated the relationship between circulating serum NFL, muscle function, and aging. The results showed that NFL levels increased with age, particularly in men. There were negative associations between NFL levels and measures of muscle function, indicating a decline in muscle performance with increasing NFL. Additionally, NFL levels were correlated with markers of body composition, such as fat mass and muscle mass, predominantly in men. Metabolomic analysis revealed significant associations between NFL levels and specific metabolites, with gender-dependent relationships observed.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

Metabolic interventions to enhance immunotherapy and targeted therapy efficacy in advanced colorectal cancer

Helena Oliveres, Marta Cascante, Joan Maurel

Summary: The current standard-of-care for metastatic colorectal cancer patients includes chemotherapy and targeted therapy, but the prognosis remains poor. New drugs combined with immune checkpoint inhibitors have been tested in microsatellite stable metastatic colorectal cancer patients, but with limited benefit. This review focuses on the metabolic interactions between the immune microenvironment and cancer cells, and highlights the potential correlation between tumor immune and metabolic features with transcriptomic classifications. The study concludes that customized strategies for modifying metabolism could improve immunotherapy and targeted therapy efficacy.

CURRENT OPINION IN CHEMICAL BIOLOGY (2023)

暂无数据